Search Results 461-470 of 18022 for Alopecia
... alopecia, radiation tissue fibrosis, or peripheral neuropathy) * Known allergies, hypersensitivity, or intolerance to JNJ-69086420 or its excipients and ...
Presence of a drug-related toxicity from prior cancer therapy that has not resolved to Grade ≤1 (with the exception of alopecia and Grade 2 neuropathy) ...
excluding alopecia. - Women of childbearing potential (WCBP) must have a negative urine or serum pregnancy test within 28 days of starting the study drug ...
0) with the exception of which inclusion criteria allowed, alopecia, vitiligo and neurotoxicity Grade ≤2 that investigator believe don't affect safety ...
Participants with diabetes Type I, vitiligo, alopecia, psoriasis, hypo- or hyperthyroid disease not requiring immunosuppressive treatment are eligible.
Adverse events from prior anti-cancer therapy resolved to ≤Grade 1 (with the exception of alopecia and anorexia). Exclusion Criteria for Phase II Portion ...
Patients not recovered to Grade 1 or stabilized from the effects (excluding alopecia) of any prior therapy for their malignancies. Concurrent treatment with ...
alopecia and stable neuropathy, which must have resolved to Grade ≤ 2 or baseline. 10. Radiotherapy, including palliative radiotherapy, completed at least ...
... alopecia \[any grade\], grade \<=2 peripheral neuropathy, or grade \<=2 hypothyroidism stable on hormone replacement) * Have an eastern cooperative oncology ...
therapy, except alopecia within 14 days prior to registration - Participants with neuropathy must have resolved to < grade 2 within 14 days prior to
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.